ACOG's 2016 Finale Fly-In: Opioid Use Disorder
Fully Fund the Improving Treatment for Pregnant and Postpartum Women Act
Over the past few years, addiction to opioids – prescription drugs or heroin – has been rising dramatically. In 2015, the Government Accountability Office (GAO) found that “the program gap most frequently cited was the lack of available treatment programs for pregnant women.”
Women need greater access to out-patient treatment options that are responsive to their complex responsibilities, as they are often the primary or sole caregivers for their families. Substance use disorder treatment must support the family unit and effectively maintain maternal sobriety as well as child well-being.
TAKE ACTION: Tell your Members of Congress to ACT NOW on this and other bipartisan women’s health priorities.
Why We Need Your Help
In July, legislation was signed into law to address these issues. The Improving Treatment for Pregnant and Postpartum Women Act passed as part of the Comprehensive Addiction and Recovery Act (P.L. 114-198) and was authorized for $16.9M for 5 years. This legislation:
Reauthorizes the Pregnant and Postpartum Women (PPW) program funded through the Substance Abuse and Mental Health Services Administration. The PPW program provides substance use disorder treatment to women in residential facilities and to their young children. Family-based treatment includes:
Individual, group, and family counseling
Prenatal and postpartum care
Training in parenting
Up to 25% of funds may be used for pilot programs to address service gaps for pregnant and postpartum women, including services in out-patient settings, and to encourage innovative models of care.
Pilot program funds are only available if total program funding exceeds fiscal year (FY) 2016 levels ($15.931M).
Solving this Problem
The Pregnant and Postpartum Women program must be funded for FY 2017 at $16.9M to ensure funds are available for innovative programs that may better serve women and their families.